In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106
Open Access
- 1 January 2013
- journal article
- Published by Springer Science and Business Media LLC in EJNMMI Research
- Vol. 3 (1), 30
- https://doi.org/10.1186/2191-219x-3-30
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Translocator Protein PET Imaging for Glial Activation in Multiple SclerosisJournal of Neuroimmune Pharmacology, 2010
- Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brainNeuropathology and Applied Neurobiology, 2009
- Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patientsJournal of the Neurological Sciences, 2008
- Quantitative analyses of 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain.2006
- Development of a New Radioligand, N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for PET Imaging of Peripheral Benzodiazepine Receptor in Primate BrainJournal of Medicinal Chemistry, 2004
- PET visualization of microglia in multiple sclerosis patients using [11C]PK11195European Journal of Neurology, 2003
- The peripheral benzodiazepine binding site in the brain in multiple sclerosisBrain, 2000
- The ECAT EXACT HR: performance of a new high resolution positron scanner.1994
- Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human SubjectsJournal of Cerebral Blood Flow & Metabolism, 1990